Abstract
Introduction (with the objective): The incorporation of technologies into the Brazilian Unified Health System (SUS) requires planning, inter-federative integration, and qualification of pharmaceutical assistance to ensure rational use, safety, and continuity of care (1). In diabetes mellitus, a condition with a high epidemiological burden, the optimization of insulin therapy is essential for glycemic control and reduction of complications (2,4). Long-acting insulins, such as glargine, have a more stable pharmacokinetic profile and a lower risk of hypoglycemia (3). In this context, the Ministry of Health instituted a pilot project for the transition from NPH insulin to glargine in priority groups (5). The REAP QUALI project (Network for Supporting the Qualification of Pharmaceutical Assistance in the SUS) consists of a national strategy of institutional support aimed at strengthening management, qualifying services, and integrating pharmaceutical assistance and health care. In Paraíba, REAP QUALI-PB plays a central role in mediating between management and services, supporting the implementation of this policy. Analyze the contribution of axis 8 (Pharmaceutical Assistance) of the REAP QUALI-PB in the organization and qualification of pharmaceutical assistance during the implementation of the pilot project for the transition from NPH insulin to glargine in Paraíba. Description: This is a descriptive, quantitative, and documentary study, based on the actions developed by the supporters of axis 8 with the state government, regional health management offices, and municipalities. Activities such as training, logistical support, dissemination of regulations, identification of eligible users, production of technical notes, and implementation of clinical and operational monitoring instruments were analyzed. At the beginning of the pilot project implementation in Paraíba (March 2026), REAP QUALI-PB acted in the articulation between the state government, 13 regional health management offices, municipalities, the Ministry of Health, and the productive sector, supporting the operationalization in the 223 municipalities. The results presented refer to the initial phase of the project. Remote and in-person training sessions were conducted on the Horus system, covering registration, dispensing, and inventory control, as well as identifying eligible patients, totaling 2,235 users qualified for the transition in this first phase. In-person workshops were held in the three macro-regions, with 693 professionals trained (260 pharmacists, 202 nurses, and 231 physicians). In the first month of the pilot project, 7,377 carpules were distributed to the regional health management offices. Weekly monitoring tools focused on safety, pharmacotherapy, and pharmacovigilance were also implemented, highlighting the initial structuring of care and logistics processes. Conclusion: Axis 8 of Pharmaceutical Assistance of the REAP QUALI-PB proved strategic in implementing the transition from NPH insulin to glargine, promoting institutional support, integration between management levels, and professional qualification. His work contributed to the organization of care flows, greater safety in the introduction of technology, and the strengthening of pharmaceutical assistance, highlighting the relevance of regionalized strategies in the successful implementation of public policies in the SUS (Brazilian Public Health System).
